Latest Articles

Publication Date
All News Scientific
Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series - BioMed Central

Sequential therapy of dienogest following relugolix for adenomyosis and impact on symptoms and serum CA125 levels: a case series BioMed Central

Published: March 29, 2025, 11:38 a.m.
Read Full Article
Inoperable Endometrial Carcinoma Treated With External Beam Radiation and a Stereotactic Body Radiation Therapy Boost - Cureus

Inoperable Endometrial Carcinoma Treated With External Beam Radiation and a Stereotactic Body Radiation Therapy Boost Cureus

Published: March 28, 2025, 4:21 p.m.
Read Full Article
Endometrial cancer patients to receive funded immunotherapy - Hong Kong Standard

Endometrial cancer patients to receive funded immunotherapy Hong Kong Standard

Published: March 27, 2025, 9:09 a.m.
Read Full Article
Future of Sclerotherapy in the Treatment of Endometriosis: A Narrative Literature Review - Cureus

Future of Sclerotherapy in the Treatment of Endometriosis: A Narrative Literature Review Cureus

Published: March 26, 2025, 7:46 a.m.
Read Full Article
Expert Opinion: Place in Therapy of Probiotics in Infertility and Recurrent Implantation Failure - Cureus

Expert Opinion: Place in Therapy of Probiotics in Infertility and Recurrent Implantation Failure Cureus

Published: March 24, 2025, 11:52 p.m.
Read Full Article
NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData - Express Pharma

NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData Express Pharma

Published: March 20, 2025, 8:30 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.
Read Full Article
NHS approval of endometriosis therapy Ryeqo enhances patient care - The Hippocratic Post

NHS approval of endometriosis therapy Ryeqo enhances patient care The Hippocratic Post

Published: March 19, 2025, 12:01 p.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!